Form 4 for AKTX Akari Therapeutics Plc
Accepted 2025-01-07 00:00:00 ET · period of report 2025-01-03 · accession 0000950170-25-002864 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-01-07 | 2025-01-03 | AKTX | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +208.0K | 5.25B | +0.0% | $0 |
| D | 2025-01-07 | 2025-01-03 | AKTX | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +152.67M | 152.67M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares, par value $0.0001 per share | 2025-01-03 | A | A | 208,000 | $0.00 | 5,249,511,500 | I PranaBio Investments LLC | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares. (F2) On January 3, 2025, the Reporting Person acquired 208,000 Ordinary Shares at a purchase price of $0.0006 per Ordinary Share. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-01-03 | A | A | 152,672,000 | $0.00 | 152,672,000 | D | $0.00 · 2025-01-03 to 2035-01-03 | 152,672,000 Ordinary Shares, par value $0.0001 per share | (F3) The stock options have an exercise price of $0.000655 per Ordinary Share. |